Overview

Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This purpose of this study is to determine the efficacy and safety of a grass sublingual (under-the-tongue) tablet.
Phase:
Phase 3
Details
Lead Sponsor:
ALK-Abelló A/S
Merck Sharp & Dohme Corp.
Treatments:
Albuterol
Fluticasone
Loratadine
Mometasone Furoate
Olopatadine Hydrochloride
Prednisone
Xhance